(Q46735206)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sabela Paradela

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Raquel Iglesias

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Rosa M Fernández-Torres

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Laida Elberdín

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

1 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

Journal of Dermatological Treatment

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

217-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

Psoriasis and its management

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Pathogenesis and clinical features of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

The cytokine and chemokine network in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Long-term response to etanercept monotherapy in moderate to severe psoriasis: assessment in daily practice by the maintenance of low values of PASI and BSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Clinical significance of immunogenicity in biologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Genome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Is 'class effect' relevant when assessing the benefit/risk profile of a biologic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2014.933166

10.3109/09546634.2014.933166

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920071%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference